Suggestions
Ilana Golant
CEO at Food Allergy Fund
Ilana Golant is the Founder and CEO of the Food Allergy Fund, a leading nonprofit dedicated to funding food allergy research.15 She established the organization in 2018, driven by her personal experience as a mother of a child with multiple food allergies.25
Golant has a diverse professional background:
- Marketing and PR executive
- Attorney
- Former government official
She has held executive positions at WPP, the world's largest advertising and PR conglomerate, and at NBCUniversal, working specifically with CNBC, MSNBC, and NBC News.15 Prior to her media career, Golant served as an attorney-advisor in the Office of Financial Stability at the U.S. Department of Treasury and worked as an attorney at Mayer Brown LLP.1
Golant's educational background includes:
- B.A. from Columbia University
- J.D. from New York University School of Law1
Under her leadership, the Food Allergy Fund aims to:
- Identify underlying causes of food allergies
- Discover new therapeutics
- Improve the lives of people living with food allergies1
The organization focuses on accelerating innovation through groundbreaking research and unique thought leadership summits.13 Golant has been instrumental in organizing these summits, bringing together experts, advocates, and stakeholders to drive progress in food allergy research and awareness.34
Highlights
I had the pleasure of talking with the author of this article about the challenges of living with food allergies and the urgent need for more diverse, practical solutions for delivering life-saving epinephrine—options that are equally as effective as injected epinephrine, more affordable, less sensitive to temperature and easy to carry.
Thanks to Teddy Rosenbluth and The New York Times for covering this development for the food allergy community.
https://lnkd.in/etyhTz9C
#foodallergy #allergic #health
In case you missed it, I'm thrilled to share the first grant recipients of the Food Allergy Fund's exclusive Drug Repurposing Challenge: Nicole Ramsey MD, PhD, FAAP and Dr. Maria Curotto de Lafaille of Mount Sinai, and Dr. Stephanie Eisenbarth and Dr. Adam Williams at Northwestern.
I'm proud that FAF is the only food allergy organization focused on this model of harnessing the power of FDA-approved drugs to end allergic diseases. This idea was inspired by my conversations with the bright minds at Every Cure. I'm feeling hopeful and excited for what's next. Stay tuned.
